News

Few musical artists in recent memory have skyrocketed to fame as quickly as Alex Warren. From his origins on social media to ...
Headwaters Capital sees deep value in Bio-Techne as academic cuts weigh on shares. Learn why this life sciences leader could ...
Census: President Trump on Thursday said he told the Department of Commerce to begin work on a new census that does not ...
Fellow Health just raised $24 million in a Series B funding round, bringing its cash haul across multiple offerings to $48 ...
Nuvectis Pharma is terminating development of NXP800 in ovarian cancer after it failed to show promise in a Phase Ia/Ib study ...
Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United ...
INF904 Phase 2a data in chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) expected by the end of September to early November 2025Phase 1/2 data announced by Staidson BioPharmaceuti ...